Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Sedative, Hypnotic, or Anxiolytic Abuse with Withdrawal Delirium (ICD-10 Code: F13.131)
Summary
This condition involves the misuse of sedative, hypnotic, or anxiolytic substances, such as benzodiazepines or barbiturates, accompanied by withdrawal delirium. It is characterized by a pattern of use that leads to clinically significant impairment or distress, with physiological or psychological reliance on the substance and the emergence of withdrawal symptoms, including delirium, when use is reduced or stopped.
Causes
The condition arises from the non-medical use of sedative, hypnotic, or anxiolytic drugs, often initiated for legitimate medical reasons (e.g., anxiety or sleep disorders) but progressing to misuse. Recreational use or overuse of these substances can disrupt normal brain function and lead to adverse behavioral or health outcomes, including withdrawal delirium when use is discontinued.
Risk Factors
- A history of substance use disorders or prior misuse of similar medications.
- Co-occurring mental health conditions, such as anxiety or depression.
- Chronic stress or exposure to environments where substance use is normalized.
- Easy access to prescription medications or recreational sedatives.
Symptoms
- Use of sedative, hypnotic, or anxiolytic substances in larger amounts or for longer durations than intended.
- Persistent desire or unsuccessful attempts to cut down or control use.
- Significant time spent obtaining, using, or recovering from the substance.
- Continued use despite social or interpersonal problems caused by use.
- Tolerance, requiring increased amounts to achieve the desired effect.
- Withdrawal symptoms, including delirium (e.g., confusion, disorientation, hallucinations, or agitation).
Diagnosis
Diagnosis is based on a clinical evaluation, including a detailed patient history and assessment of substance use patterns. Healthcare providers may use standardized criteria (e.g., DSM-5) to confirm the presence of withdrawal delirium. Laboratory tests or imaging may be used to rule out other conditions, but clinical judgment is primary.
Treatment Options
Treatment focuses on managing withdrawal symptoms, including delirium, and addressing the underlying substance use disorder. This may involve medical detoxification, supportive care, and pharmacotherapy to stabilize the patient. Long-term treatment often includes behavioral therapy, counseling, and support groups to prevent relapse.
Prognosis and Follow-Up
Prognosis depends on the severity of the condition, the individual’s response to treatment, and the presence of co-occurring disorders. With appropriate care, many patients can achieve recovery, but relapse is possible. Regular follow-up is essential to monitor progress, adjust treatment, and address any emerging issues.
Complications
- Severe withdrawal symptoms, including delirium, which can be life-threatening.
- Increased risk of accidents or injuries due to impaired judgment.
- Worsening of co-occurring mental health conditions.
- Long-term cognitive or neurological damage if delirium is prolonged or severe.
Lifestyle & Prevention
- Avoid non-medical use of sedative, hypnotic, or anxiolytic substances.
- Follow prescribed medication regimens closely and discuss concerns with a healthcare provider.
- Seek help for stress or mental health issues to reduce reliance on substances.
- Maintain a supportive environment and engage in healthy coping strategies.
When to Seek Professional Help
Seek immediate medical attention if experiencing confusion, hallucinations, severe agitation, or other signs of withdrawal delirium. Contact a healthcare provider for ongoing substance use concerns or if unable to control use despite negative consequences.
Tips for Medical Coders
Document the presence of withdrawal delirium and its relationship to sedative, hypnotic, or anxiolytic abuse clearly in the medical record. Ensure the diagnosis aligns with clinical criteria and that any contributing factors (e.g., substance use history) are noted. Use this code only when withdrawal delirium is a direct result of the substance abuse.
F13.131 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.